Literature DB >> 15890892

Distribution of LDL particle size in a population-based sample of children and adolescents and relationship with other cardiovascular risk factors.

Simona Stan1, Emile Levy, Edgard E Delvin, James A Hanley, Benoît Lamarche, Jennifer O'Loughlin, Gilles Paradis, Marie Lambert.   

Abstract

BACKGROUND: Smaller, denser LDL particles are associated with an increased risk for cardiovascular diseases (CVD). In youths, data on the distribution of LDL particle size and on its association with other CVD risk factors are limited.
METHODS: We determined LDL peak particle size by nondenaturing 2%-16% gradient gel electrophoresis in a representative sample of 2249 youths 9, 13, and 16 years of age who participated in a school-based survey conducted in 1999 in the province of Quebec, Canada. Standardized clinical measurements and fasting plasma lipid, glucose, and insulin concentrations were available.
RESULTS: The LDL peak particle size distribution was gaussian. The 5th, 50th (median), and 95th percentiles by age and sex were 255.5-258.6, 262.1-263.2, and 268.1-269.5 A, respectively. The prevalence of the small, dense LDL phenotype (LDL peak particle size <or=255 A) was 10% in participants with insulin resistance syndrome (IRS), in contrast to 1% in those without IRS. In a multiple regression analysis, the association of LDL size with other CVD risk factors [apolipoprotein B, HDL-cholesterol (HDL-C), triglyceride (TG), and insulin concentrations, and body mass index] was strongest with TG and HDL-C concentrations: a 1 SD increase in log(e)-transformed TG concentration was associated with a 1.2 A reduction in LDL size, and a 1 SD increase in HDL-C was associated with a 1.1 A increase in LDL size.
CONCLUSIONS: Although the small, dense LDL phenotype is less prevalent in youths than adults, its prevalence is clearly increased in childhood IRS. Metabolic correlates of LDL size are similar in youths and adults.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890892     DOI: 10.1373/clinchem.2004.046771

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  18 in total

1.  Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors.

Authors:  Sophia Morel; Jade Leahy; Maryse Fournier; Benoit Lamarche; Carole Garofalo; Guy Grimard; Floriane Poulain; Edgard Delvin; Caroline Laverdière; Maja Krajinovic; Simon Drouin; Daniel Sinnett; Valérie Marcil; Emile Levy
Journal:  J Lipid Res       Date:  2017-03-08       Impact factor: 5.922

Review 2.  A comprehensive view of sex-specific issues related to cardiovascular disease.

Authors:  Louise Pilote; Kaberi Dasgupta; Veena Guru; Karin H Humphries; Jennifer McGrath; Colleen Norris; Doreen Rabi; Johanne Tremblay; Arsham Alamian; Tracie Barnett; Jafna Cox; William Amin Ghali; Sherry Grace; Pavel Hamet; Teresa Ho; Susan Kirkland; Marie Lambert; Danielle Libersan; Jennifer O'Loughlin; Gilles Paradis; Milan Petrovich; Vicky Tagalakis
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

3.  Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease.

Authors:  Kathleen E Corey; Raj Vuppalanchi; Miriam Vos; Rohit Kohli; Jean P Molleston; Laura Wilson; Aynur Unalp-Arida; Oscar W Cummings; Joel E Lavine; Naga Chalasani
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-03       Impact factor: 2.839

4.  In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children.

Authors:  Stephen F Burns; SoJung Lee; Silva A Arslanian
Journal:  Diabetes Care       Date:  2009-08-12       Impact factor: 17.152

5.  Diet does not explain the high prevalence of dyslipidaemia in paediatric renal transplant recipients.

Authors:  Arja Siirtola; Suvi M Virtanen; Marja Ala-Houhala; Anna-Maija Koivisto; Tiina Solakivi; Terho Lehtimäki; Christer Holmberg; Marjatta Antikainen; Matti K Salo
Journal:  Pediatr Nephrol       Date:  2007-11-15       Impact factor: 3.714

6.  Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia.

Authors:  Jyoti Malhotra; Emily S Tonorezos; Marina Rozenberg; Gloria L Vega; Charles A Sklar; Joanne Chou; Chaya S Moskowitz; Debra A Eshelman-Kent; Peter Janiszewski; Robert Ross; Kevin C Oeffinger
Journal:  J Lipid Res       Date:  2012-09-13       Impact factor: 5.922

7.  Tracking and determinants of LDL particle size in healthy children from 7 to 11 years of age: the STRIP Study.

Authors:  Tuuli Kaitosaari; Olli Simell; Jorma Viikari; Olli Raitakari; Marja Siltala; Maarit Hakanen; Aila Leino; Eero Jokinen; Tapani Rönnemaa
Journal:  Eur J Pediatr       Date:  2008-07-05       Impact factor: 3.183

8.  Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults.

Authors:  Elaine M Urbina; Philip R Khoury; Connie E McCoy; Lawrence M Dolan; Stephen R Daniels; Thomas R Kimball
Journal:  Pediatrics       Date:  2013-03-04       Impact factor: 7.124

9.  LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

Authors:  Kazuhiko Kotani; Kokoro Tsuzaki; Nobuyuki Taniguchi; Naoki Sakane
Journal:  Int J Prev Med       Date:  2012-03

10.  Arterial stiffness in adolescents and young adults with and without type 1 diabetes: the SEARCH CVD study.

Authors:  Amy S Shah; R Paul Wadwa; Dana Dabelea; Richard F Hamman; Ralph D'Agostino; Santica Marcovina; Stephen R Daniels; Lawrence M Dolan; Nora F Fino; Elaine M Urbina
Journal:  Pediatr Diabetes       Date:  2015-04-24       Impact factor: 4.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.